
Coya Therapeutics, Inc.
COYAHealthcare|Biotechnology|US
$2.99
+0.18 (+6.41%)
DCF Value
$4.73
Tangible Book / Share
$1.84
Cash / Share
$1.84
Next Earnings Report
Nov 11, 2026
EPS est. -$0.35 · Revenue est. $110.0K
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest May 12, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (1)
Apr 2027
Est. completion
Recent Press Releases
Coya to Initiate Open-Label Extension of Phase 2/3 ALSTARS Trial of COYA 302 in ALS
Oct 14, 2026 · Business Wire
Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
Oct 13, 2026 · Business Wire
Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
Oct 5, 2026 · Business Wire
Coya Therapeutics Announces Enrollment of 100th Participant in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
Sep 15, 2026 · Business Wire
Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation
Sep 8, 2026 · Business Wire
Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Aug 11, 2026 · Business Wire
SEC Filings (57)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 14, 2026 | 8-K | Material event | DocumentIndex |
| Oct 5, 2026 | 8-K | Material event | DocumentIndex |
| Sep 15, 2026 | 8-K | Material event | DocumentIndex |
| Aug 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 11, 2026 | 8-K | Material event | DocumentIndex |
| Aug 7, 2026 | 8-K/A | Material event | DocumentIndex |
| Jul 27, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jun 25, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | ARS | Annual report to holders | DocumentIndex |
| May 13, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| May 13, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 12, 2026 | 8-K | Material event | DocumentIndex |
| May 12, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| May 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2026 | 8-K | Material event | DocumentIndex |
| Apr 2, 2026 | 8-K | Material event | DocumentIndex |
| Mar 20, 2026 | EFFECT | DocumentIndex | |
| Mar 20, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Mar 16, 2026 | S-3 | Shelf registration | DocumentIndex |
| Mar 16, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 16, 2026 | 8-K | Material event | DocumentIndex |
| Mar 12, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 30, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 30, 2026 | 8-K | Material event | DocumentIndex |
| Jan 28, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 20, 2026 | 8-K | Material event | DocumentIndex |
| Jan 8, 2026 | 8-K | Material event | DocumentIndex |
| Dec 17, 2025 | 8-K | Material event | DocumentIndex |
| Nov 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 12, 2025 | 8-K | Material event | DocumentIndex |
| Oct 27, 2025 | 8-K | Material event | DocumentIndex |
| Oct 27, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Oct 23, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Sep 2, 2025 | 8-K | Material event | DocumentIndex |
| Aug 19, 2025 | EFFECT | DocumentIndex | |
| Aug 19, 2025 | 424B7 | Offering prospectus | DocumentIndex |
| Aug 12, 2025 | S-3 | Shelf registration | DocumentIndex |
| Aug 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2025 | 8-K | Material event | DocumentIndex |
| Jul 29, 2025 | 8-K | Material event | DocumentIndex |